TP53 and neoplasm: Analysis of a spectrum of p53 mutants revealed that each p53 mutation creates different subtypes of structural lesions, and each uniquely changes protein conformation; thus, tumor-derived mutants of p53 may require subtype- or mutant-selective strategies (16).